Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women

• Status: Completed
• Trial end date: 2013-06-06
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators propose to assess if a non-hormonal agent is absorbed by a local route (vaginal) and to observe the effect on follicular development.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Laboratorios Andromaco S.A.
• Collaborator: Instituto Chileno de Medicina Reproductiva
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Meloxicam

Criteria

Inclusion Criteria:

• Previous (or history of) proven fertility

• Regular menstrual cycle

• Surgically sterile

• Without breastfeeding

• Haemoglobin at least 11g/dL

• Willing to participate in the study

Exclusion Criteria:

• Allergy to meloxicam or other NSAID

• Allergy to silicone polymer

• Vaginal discharge non diagnosticated

• History of shock toxic syndrome

• History of : gastrointestinal, bleeding, renal, liver, heart, brain,clot, endocrine or pulmonary disorders